Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $16.36 million. The enterprise value is -$8.58 million.

Market Cap	16.36M
Enterprise Value	-8.58M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

APRE has 5.43 million shares outstanding. The number of shares has increased by 47.99% in one year.

Current Share Class	5.43M
Shares Outstanding	5.43M
Shares Change (YoY)	+47.99%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	11.75%
Owned by Institutions (%)	29.71%
Float	3.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.38
Forward PS	n/a
PB Ratio	0.75
P/TBV Ratio	0.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.28

Current Ratio	7.28
Quick Ratio	7.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.22% and return on invested capital (ROIC) is -41.15%.

Return on Equity (ROE)	-60.22%
Return on Assets (ROA)	-35.06%
Return on Capital (ROIC)	-41.15%
Revenue Per Employee	$187,263
Profits Per Employee	-$1.93M
Employee Count	7
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.16% in the last 52 weeks. The beta is 1.74, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	-20.16%
50-Day Moving Average	3.33
200-Day Moving Average	4.59
Relative Strength Index (RSI)	36.27
Average Volume (20 Days)	14,045

Short Selling Information

The latest short interest is 28,953, so 0.53% of the outstanding shares have been sold short.

Short Interest	28,953
Short Previous Month	15,177
Short % of Shares Out	0.53%
Short % of Float	0.73%
Short Ratio (days to cover)	0.55

Income Statement

In the last 12 months, APRE had revenue of $1.31 million and -$13.51 million in losses. Loss per share was -$2.73.

Revenue	1.31M
Gross Profit	-7.74M
Operating Income	-14.77M
Pretax Income	-12.72M
Net Income	-13.51M
EBITDA	-14.75M
EBIT	-14.77M
Loss Per Share	-$2.73

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	26.25M
Total Debt	n/a
Net Cash	26.25M
Net Cash Per Share	$4.83
Equity (Book Value)	23.26M
Book Value Per Share	4.04
Working Capital	22.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.79 million and capital expenditures -$22,628, giving a free cash flow of -$13.81 million.

Operating Cash Flow	-13.79M
Capital Expenditures	-22,628
Free Cash Flow	-13.81M
FCF Per Share	-$2.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,126.65%
Pretax Margin	-1,030.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,364.34%

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.99%
Shareholder Yield	-47.99%
Earnings Yield	-82.57%
FCF Yield	-84.41%

Analyst Forecast

The average price target for APRE is $15.50, which is 414.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	414.95%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	142.36%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

APRE has an Altman Z-Score of -13.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.75
Piotroski F-Score	3